These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32283242)

  • 21. Which are the "emergent" dermatologic practices during COVID-19 pandemic? Report from the lockdown in Milan, Italy.
    Giacalone S; Bortoluzzi P; Nazzaro G
    Int J Dermatol; 2020 Aug; 59(8):e269-e270. PubMed ID: 32501536
    [No Abstract]   [Full Text] [Related]  

  • 22. Continuation of minimally invasive surgery in the COVID-19 pandemic.
    Huddy JR; Rasheed S; Tilney HS
    Tech Coloproctol; 2020 Oct; 24(10):1105-1106. PubMed ID: 32845405
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of 3D technology to support dermatologists returning to practice amid COVID-19.
    Ishack S; Lipner SR
    Cutis; 2020 Sep; 106(3):140-141. PubMed ID: 33104123
    [No Abstract]   [Full Text] [Related]  

  • 24. Head and neck surgery recommendations during the COVID-19 pandemic.
    Galloway TJ; Kowalski LP; Matos LL; Junior GC; Ridge JA
    Lancet Oncol; 2020 Sep; 21(9):e416. PubMed ID: 32888466
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 and its effect on medical student education in dermatology.
    Loh TY; Hsiao JL; Shi VY
    J Am Acad Dermatol; 2020 Aug; 83(2):e163-e164. PubMed ID: 32413448
    [No Abstract]   [Full Text] [Related]  

  • 26. Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery.
    Do MH; Minkis K; Petukhova TA; Lipner SR
    J Am Acad Dermatol; 2020 Oct; 83(4):e307-e308. PubMed ID: 32603720
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of COVID-19 outbreak on dermatology services: Dermatology in isolation.
    Damevska K; Neloska L; Simeonovski V; Petrov A; Dimitrovska I; Teovska-Mitrevska N; Najdova A; Pollozhani N
    Dermatol Ther; 2020 Jul; 33(4):e13552. PubMed ID: 32390176
    [No Abstract]   [Full Text] [Related]  

  • 28. How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.
    Jessica Chang TY; Pope JE
    Immunotherapy; 2020 Oct; 12(15):1115-1119. PubMed ID: 32640861
    [No Abstract]   [Full Text] [Related]  

  • 29. Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
    Shanshal M
    J Drugs Dermatol; 2020 Apr; 19(4):436. PubMed ID: 32401460
    [No Abstract]   [Full Text] [Related]  

  • 30. The coronavirus (COVID-19) epidemic and patient safety.
    Elston DM
    J Am Acad Dermatol; 2020 Apr; 82(4):819-820. PubMed ID: 32074487
    [No Abstract]   [Full Text] [Related]  

  • 31. Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic.
    Shah M; Naik HB; Alhusayen R
    J Am Acad Dermatol; 2020 Jul; 83(1):e81-e82. PubMed ID: 32360857
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic.
    Pathoulas JT; Stoff BK; Lee KC; Farah RS
    J Am Acad Dermatol; 2020 May; 82(5):1272-1273. PubMed ID: 32224276
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.
    Sadoughifar R; Goldust M; Kroumpouzos G; Szepietowski JC; Lotti T; Sandhu S
    Dermatol Ther; 2020 Jul; 33(4):e13562. PubMed ID: 32396251
    [No Abstract]   [Full Text] [Related]  

  • 34. The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology.
    Micali G; Musumeci ML; Peris K;
    G Ital Dermatol Venereol; 2020 Apr; 155(2):123-125. PubMed ID: 32394672
    [No Abstract]   [Full Text] [Related]  

  • 35. Publishing in the time of pandemic: Editorial policy of a dermatology journal during COVID-19.
    Panda S
    Indian J Dermatol Venereol Leprol; 2020; 86(4):337-340. PubMed ID: 32525104
    [No Abstract]   [Full Text] [Related]  

  • 36. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
    Nassim D; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):420-421. PubMed ID: 32449619
    [No Abstract]   [Full Text] [Related]  

  • 37. PRACTITIONER APPLICATION: Rapid Systemwide Implementation of Outpatient Telehealth in Response to the COVID-19 Pandemic.
    Thielman S
    J Healthc Manag; 2020; 65(6):452-454. PubMed ID: 33186261
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary: Pandemic deployment and surgical soldiership.
    Goldstein DJ
    J Thorac Cardiovasc Surg; 2020 Oct; 160(4):952-953. PubMed ID: 32622576
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical care during the new coronavirus (Covid-19) pandemic].
    Fedorov AV; Kurganov IA; Emelyanov SI
    Khirurgiia (Mosk); 2020; (9):92-101. PubMed ID: 33030009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the dermatology communities' public health response to COVID-19.
    Gorrepati PL; Smith GP
    Dermatol Ther; 2020 Jul; 33(4):e13775. PubMed ID: 32506777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.